Brazil Medical Device Registration
Important Notes
- ANVISA as the Central Regulatory Authority: All medical devices require marketing authorization from ANVISA, involving complex and stringent registration processes.
- Risk-Based Device Classification: Medical devices are classified into Class I-IV based on risk level, with differentiated registration pathways and technical documentation requirements.
- Brazilian Local Registration Holder Requirement: A foreign manufacturer must appoint a legal entity established in Brazil as the Registration Holder, assuming full lifecycle legal responsibility for the product.
- Mandatory Portuguese Documentation & Labeling: All technical dossiers, labels, and instructions must be in Brazilian Portuguese. Labeling regulations are extremely detailed, with non-compliance risking registration failure or penalties.
- Localized Good Manufacturing Practice Inspections: ANVISA conducts rigorous and frequent BGMP inspections for both domestic and foreign manufacturing sites, with standards considered among the world's toughest.
- Deep Integration with MERCOSUR Technical Regulations: As a key driver of MERCOSUR, Brazil's medical device regulations are deeply harmonized with regional resolutions, making it central to any regional strategy.
Brazil Specific Requirements
- Massive but High-Barrier Primary Latin American Market: Brazil offers the largest medical device consumption market in Latin America, coupled with some of the world's most complex, stringent, and costly regulatory hurdles.
- Unified Health System as Market Foundation & Major Payer: The public SUS is the largest single purchaser of medical devices and essential health products, its tender rules profoundly shaping market dynamics and pricing.
- Strong Preference for Local Clinical Trial Data: For innovative medical devices, ANVISA typically requires local clinical trial data involving Brazilian populations, often becoming the most time-consuming step for market entry.
- Mature & Booming Medical Device Demand: Brazil has one of Latin America's largest medical device markets, with immense demand for diagnostic, therapeutic, and monitoring devices, albeit in a highly competitive landscape.
- Regional Regulatory Beacon & Manufacturing Hub: ANVISA is a benchmark for regulatory capacity in Latin America, and Brazil's advanced medical device industry makes it a key regional manufacturing and export center.
Medical Devices Registration
Regulatory Requirements
- Product Registration (Cadastro/Registro de Produto)
- Risk-based classification system (Class I-IV) according to RDC 185/2001
- Brazilian Good Manufacturing Practices (BGMP) certification for Class II-IV devices
- Complete technical documentation and test reports
- Portuguese labeling and instructions for use
- Certificate of Free Sale from country of origin
- Clinical evaluation and performance data
- Biocompatibility testing per ISO 10993 (where applicable)
- Electrical safety and electromagnetic compatibility testing
- Risk management documentation according to ISO 14971
Main Process
- Product classification determination
- Technical documentation preparation
- BGMP certification acquisition
- ANVISA review submission
- Product registration certificate acquisition
Registration Timeline
8-24 months
Official Fees
BRL 5,000 - 80,000
Service Fees
$15,000 - $50,000
Regulatory System Overview
ANVISA
Brazilian Health Regulatory Agency (Agência Nacional de Vigilância Sanitária)
Responsible for medical device registration approvals, quality supervision, and market surveillance. The core health regulatory authority in Brazil, operating under the national regulatory framework. Regulatory scope includes: medical device registration, BGMP certification, and post-market vigilance.
Medical Devices Registration Process
Regulatory Classification
Determine medical device risk classification (Class I-IV) and applicable registration pathway according to ANVISA RDC 185/2001
BGMP Certification
Obtain Brazilian Good Manufacturing Practices certificate (mandatory for Class II and above devices)
Technical Documentation Preparation
Prepare comprehensive technical documentation including test reports and Portuguese labeling
ANVISA Application Submission
Submit product registration application through Brazilian local representative (Detentor)
Post-Market Surveillance
Establish technical complaints, adverse event reporting, and vigilance system as per ANVISA requirements